Abstract
The novel PET probe 2-deoxy-2-18F-fluoro-d-sorbitol (18F-FDS) has demonstrated favorable renal kinetics in animals. We aimed to elucidate its imaging properties in 2 human volunteers. 18F-FDS was produced by a simple 1-step reduction from 18F-FDG. On dynamic renal PET, the cortex was delineated and activity gradually transited in the parenchyma, followed by radiotracer excretion. No adverse effects were reported. Given the higher spatiotemporal resolution of PET relative to conventional scintigraphy, 18F-FDS PET offers a more thorough evaluation of human renal kinetics. Due to its simple production from 18F-FDG, 18F-FDS is virtually available at any PET facility with radiochemistry infrastructure.
Original language | English (US) |
---|---|
Pages (from-to) | 410-411 |
Number of pages | 2 |
Journal | Clinical nuclear medicine |
Volume | 44 |
Issue number | 5 |
DOIs | |
State | Published - May 1 2019 |
Keywords
- 18F-FDS
- 2-deoxy-2-18F-fluoro-d-sorbitol
- PET
- kidney
- renal imaging
- split renal function
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging